Northeastern University

Perform hands-on research in an

NCI-funded lab

Perform hands-on research in an

NCI-funded lab

Trainees
0
Publications
0
Laboratories
0
Awards
0
Higher Degrees
0

Our Current Trainees

Behavioral Neuroscience, '25

Metabolic Signatures and Corresponding Cell Type Populations in Different Grades of Glioma

Biochemistry, '26

SuperT Antigen in Merkel Cell Carcinoma

Cell and Molecular Biology, '25

Investigating Personalized Cancer Vaccine Approaches for the Treatment of Chronic Lymphocytic Leukemia

Behavioral Neuroscience, '25

Understanding the Border Between Normal Physiological Stemness and Tumor Differentiation in Colon Cancer

Health Science, '25

Utilization and Production of Antibody Drug Conjugates for Lung Cancer Treatment

Health Science, '25

Exploring the Role of Inflammatory Caspases in Protein Translation Inhibition

Biology, '26

(MALDI-TOF) to Detect Precursor Conditions for Multiple Myeloma in High-Risk Populations

Cell and Molecular Biology, '25

Detecting Brain Metastasis from Extracellular Vesicles in Cerebrospinal Fluid

What if you could buy a cancer test at your local store, take it to the privacy of your own home, and get the results immediately?  This vision inspired me to develop a cervical cancer screening test with CaNCURE. A year later, I returned to the same lab to field test my device in Botswana…

 

Victoria D’Agostino, ’19

PhD Candidate, Ctr for Global Women’s Health Technologies, Duke University

Past Trainees

Bioengineering and Biochemistry, '23

Development of In Vivo Tumor Models and Methods for Exploring Biological Markers Associated with Tumor Spread Through Air Spaces (STAS) and Gaining Insight into Mechanisms that Facilitate STAS Metastasis Patterns in Lung Cancers

Cell and Molecular Biology, '23

Investigating resistance mechanisms and clonal dynamics in heterogeneous ovarian cancer cells using a multi-functional lineage tracing tool

Chemical Engineering and Biochemistry, '23

Photodynamic Therapy Mediated Enhancement of Immune Checkpoint Therapy in Pancreatic Tumor Organoids

Chemical Engineering, '23

Combined Delivery of PARP Inhibitors and STING Agonists for Treatment of Ovarian Cancer

Bioengineering, '23

Investigating Caspase-Mediated Activation of the IL-1 Family

Biology, '23

Screening High-Risk Populations for Multiple Myeloma Precursors via the PROMISE Study

Biochemistry, '23

Characterization of Nanoparticle Uptake in the Nano-SMART Clinical Trial

Behavioral Neuroscience, '23

Role of Th1 Cells in the Development of Colorectal Cancers

Biochemistry, '25

Multiplexed Digital ELISA Assay for Early Pancreatic Cancer Detection

Behavioral Neuroscience, '25

Sustained Release Talazoparid for Treatment of BRCA1 Deficient Breast Cancer

Behavioral Neuroscience, '25

Diffuse Intrinsic Pontine Glioma (DIPG) and Brainstem Tumors in Pediatric Patients

Biology, '25

Early Diagnosis of Acute Kidney Injury

Biochemistry, '24

Lipid Nanoparticles for the Delivery of Tumor Suppressor mRNA

Public Health & Health Science, '24

Understanding and Overcoming Resistance to PARP Inhibitors in Ovarian Cancer Patients

Biochemistry, '24

Characterizing Resistance to Immunogenic Cell Death in the Treatment Multiple Myeloma with Bortezomib

Biochemistry, '24

Transcriptional Targets of p53 in Merkel Cell Carcinoma (MCC)

Health Sciences, '24

Screening for Multiple Myeloma Precursors in a High-Risk Population using Mass Spectrometry

Biology, '24

Localized Delivery of PARP Inhibitors for the Treatment of Ovarian Cancer

Biochemistry, '24

Minor Histocompatibility Antigen Validation

Cell & Mollecular Biology, '24

A Dual Function Antibody Conjugate for Tumor Targeted Molecular Imaging and Treatment

Bioengineering & Biochemistry, '24

Liver-mediated epigenetic reprogramming of CRC primary tumor drives metastasis

Health Sciences, '24

Using Gapmers in Multiple Myeloma to Increase Immune Response

Bioengineering and Biochemistry, '24

Renal Imaging using a Ferumoxytol Nanoparticle Contrast Agent

Behavioral Neuroscience, '24

Nano-formulations and Sustained Delivery of Combination Therapy of TLZ with CER or ALP to Overcome PARPi Resistance for Ovarian Cancer Treatment